ORAMED PHARMACEUTICALS INC. (ORMP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$2.44M2012: -$2.88M2013: $4.30M2014: -$5.91M2015: -$7.38M2016: -$10.01M2017: -$10.77M2018: -$13.53M2019: -$14.63M2020: -$11.76M2021: -$24.22M2022: -$40.60M2023: -$15.77M2024: -$12.78M2025: -$15.09M-$15.09M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$15.09M-18.1%
2024-$12.78M+18.9%
2023-$15.77M+61.2%
2022-$40.60M-67.6%
2021-$24.22M-106.0%
2020-$11.76M+19.6%
2019-$14.63M-8.2%
2018-$13.53M-25.6%
2017-$10.77M-7.6%
2016-$10.01M-35.6%
2015-$7.38M-25.0%
2014-$5.91M-237.2%
2013$4.30M+249.2%
2012-$2.88M-18.4%
2011-$2.44M